General Information of the Compound
| Compound ID |
CP0391075
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
Dexilant
Show/Hide
|
||||||||||||||||||
| Synonyms |
Kapidex
(R)-2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
(R)-Lansoprazole
(r)-(+)-lansoprazole
138530-94-6
2-((R)-((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
AK170558
Dexilant Solutab
Dexlansoprazole
Dexlansoprazole (INN/USAN)
KS-1075
Kapidex
Lansoprazole
R-(+)-LANSOPRAZOLE
T 168390
T-168390
TAK 390
TAK-390
TAK-390MR
UNII-UYE4T5I70X
UYE4T5I70X
dexilant
dexlansoprazole
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H14F3N3O2S
|
||||||||||||||||||
| Molecular Weight |
369.368
|
||||||||||||||||||
| Canonical SMILES |
Cc1c(OCC(F)(F)F)ccnc1C[S@@+]([O-])c1nc2ccccc2[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MJIHNNLFOKEZEW-RUZDIDTESA-N
|
||||||||||||||||||
| CAS |
138530-94-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02089, Cytosolic endo-beta-N-acetylglucosaminidase
Protein ID: PT06480, NAD(+) hydrolase SARM1
Clinical Information about the Compound